Surgical Treatment Options in Thumb Carpometacarpal Osteoarthritis: A Recent Literature Overview Searching for Practice Pattern with Special Focus on Total Joint Replacement [0.03%]
第一腕掌关节骨关节炎的外科治疗选择：最新文献综述，重点关注全关节置换术的实践模式
Ingo Schmidt
Ingo Schmidt
Thumb carpometacarpal joint osteoarthritis is the most common site of non-rheumatic degenerative lesion in the hand, and there are special features in rheumatic patients. None of various surgical treatment options can be declared as "gold s...
The Peri-operative Management of the Rheumatoid Patient Undergoing Total Knee Arthroplasty: A Review of Literature [0.03%]
类风湿性关节炎患者行全膝关节置换术的围手术期管理文献回顾
Mohammad Z Sohail,Nick Aresti,Sammy A Hanna et al.
Mohammad Z Sohail et al.
Rheumatoid arthritis is the commonest inflammatory arthropathy, and affects synovium, cartilage and bone. Despite recent improvements with disease modifying biological agents, progressive joint destruction may continue eventually leading to...
Complications Encountered with Total Hip Arthroplasty in Rheumatoid Patients [0.03%]
类风湿患者全髋关节置换的并发症问题
Nick A Aresti,Wasim S Khan,Atif Malik
Nick A Aresti
Rheumatoid arthritis affects around 1% of the global population with a predilection for Western societies. The treatment of the rheumatoid hip has gone through significant changes in recent years. Although osteotomies and synovectomies were...
US Guided Treat-to-Target Approach in Early RA: Implications for Uncoupling of Disease Activity and Structural Joint Damage [0.03%]
早期RA中美国倡导的治疗目标方法：疾病活动和结构关节损伤分离的意义
Yasser El Miedany,Maha El Gaafary,Ihab Ahmed et al.
Yasser El Miedany et al.
Objective: To assess the relationship between disease activity, measured by DAS28, and radiographic progression, using X-Ray and US as tools to evaluate structural joint damage and residual inflammation, in early RA patie...
Can Tocilizumab Decrease Cartilage Oligomeric Matrix Protein Levels and Disease Activity in Patients with Long-Standing Rheumatoid Arthritis? [0.03%]
托珠单抗能否降低长期类风湿关节炎患者的 cartilage寡聚蛋白多糖蛋白水平和疾病活动度？
Maurizio Benucci,Francesca Meacci,Mariangela Manfredi et al.
Maurizio Benucci et al.
Serum cartilage oligomeric matrix protein (COMP) level is a new marker of joint destruction in patients with rheumatoid arthritis (RA), and a new means of identifying patients with progressive joint damage. To evaluate the effect of tociliz...
Diagnosis of systemic lupus erythematosus in an unusual presentation: what a primary care physician should know [0.03%]
系统性红斑狼疮不典型表现的诊断：全科医生应该知道什么
Bimalendu Pramanik
Bimalendu Pramanik
Systemic Lupus Erythematosus (SLE) is a multisystem autoimmune disease affecting millions of people worldwide. It can affect any organ systems of the body. However, all systems may not be involved initially rather than they may be affected ...
Can tocilizumab decrease cartilage oligomeric matrix protein levels and disease activity in patients with long-standing rheumatoid arthritis? [0.03%]
托珠单抗能否降低长期患有类风湿性关节炎患者的软骨寡聚矩阵蛋白水平和疾病活性？
Maurizio Benucci,Francesca Meacci,Mariangela Manfredi et al.
Maurizio Benucci et al.
Serum cartilage oligomeric matrix protein (COMP) level is a new marker of joint destruction in patients with rheumatoid arthritis (RA), and a new means of identifying patients with progressive joint damage. To evaluate the effect of tociliz...
Association of anti-cyclic citrullinated peptide antibodies with clinical and radiological disease severity in rheumatoid arthritis [0.03%]
抗环瓜氨酸肽抗体与类风湿性关节炎临床及放射学疾病严重程度的关系
Ankit Gupta,Reshma Kaushik,Rajeev M Kaushik et al.
Ankit Gupta et al.
Objective: This study assessed an association of anti-cyclic citrullinated peptide antibodies (ACPA) with clinical and radiological disease severity in patients with rheumatoid arthritis (RA). ...
Amir Oron,Ronit Wollstein
Amir Oron
The human wrist is a composite joint which incorporates multiple smaller joints. The biomechanics of the wrist are dependent on its bony structure but also on the ligamentous constitution of its joints. This increases the complexity of the ...
Yasser El Miedany
Yasser El Miedany
Monitoring treatment effects can inform both the physician and patient whether the medication has achieved its anticipated targets. There are several variances between patients cohorts included in clinical trials and subjects managed in sta...